MedTrace Logo

3 Year Follow up on ANO5 Patients

NCT05206617 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2025-04-06

No results posted yet for this study

Summary

The aim of the study is to investigate progression in muscle affection in patients with pathogenic variants in the anoctamin 5 gene to:

1. investigate possible progression of disease over time
2. investigate good and reliable outcome measures

Conditions

Interventions

OTHER

No intervention - pure observational study

No intervention

Sponsors & Collaborators

  • Funding: Toyota Foundation

    collaborator UNKNOWN

  • The Hede Nielsen Family Foundation

    collaborator OTHER

  • Funding: Grosserer L. F. Foghts Foundation

    collaborator UNKNOWN

  • Funding: Torben og Alice Frimodts Foundation

    collaborator UNKNOWN

  • Funding: Aase og Ejnar Danielsens Foundation

    collaborator UNKNOWN

  • Funding: Oda og Hans Svenningens Foundation

    collaborator UNKNOWN

  • Funding: Torkild Steensbecks Legat

    collaborator UNKNOWN

  • Funding: Foundation for research in Neurology

    collaborator UNKNOWN

  • Rigshospitalet, Denmark

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2021-06-01
Completion
2026-11-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05206617 on ClinicalTrials.gov